Evidence map›Paper›PMID 20850481›Full record

ArticleBiochimica et biophysica acta2011

ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells.

Ann K Y To, George G Chen, Ursula P F Chan, Caiguo Ye, Jing P Yun, Rocky L K Ho, Art Tessier, Juanita L Merchant, Paul B S Lai

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The anticancer effects of Resina Draconis extract on cholangiocarcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ann K Y ToDepartment of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
George G Chen
Ursula P F Chan
Caiguo Ye
Jing P Yun
Rocky L K Ho
Art Tessier
Juanita L Merchant
Paul B S Lai
Chinese University of Hong Kong · HKUniversity of Michigan · USSun Yat-sen University · CN

Funding

Mechanisms of Gastrointestional Growth &TransformationR01DK055732 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MERCHANT, JUANITA L. · 2000 to 2014
$4.1M
NIDDK NIH HHS R01 DK055732NIDDK NIH HHS R01 DK-55732
6 · The paper itself

Abstract

ZBP-89 can enhance tumor cells to death stimuli. However, the molecular mechanism leading to the inhibitory effect of ZBP-89 is unknown. In this study, 4 liver cell lines were used to screen for the target of ZBP-89 on cell death pathway. The identified Bak was further analyzed for its role in ZBP-89-mediated apoptosis. The result showed that ZBP-89 significantly and time-dependently induced apoptosis. It significantly upregulated the level of pro-apoptotic Bak. ZBP-89 targeted a region between -457 and -407 of human Bak promoter to stimulate Bak expression based on the findings of Bak promoter luciferase report gene assay and electrophoretic mobility shift assay. ZBP-89-induced Bak increase and ZBP-89-mediated apoptosis were markedly suppressed by Bak siRNA, confirming that Bak was specifically targeted by ZBP-89 to facilitate apoptosis. In conclusion, this study demonstrated that ZBP-89 significantly induced apoptosis of HCC cells via promoting Bak level.

Indexed as

Apoptosisbcl-2 Homologous Antagonist-Killer ProteinBlotting, WesternCarcinoma, HepatocellularCell ProliferationDNA-Binding ProteinsElectrophoretic Mobility Shift AssayHumansLiver NeoplasmsLuciferasesPromoter Regions, GeneticRNA, Small InterferingTranscription FactorsTumor Cells, CulturedBAK1 protein, humanbcl-2 Homologous Antagonist-Killer ProteinDNA-Binding ProteinsLuciferasesRNA, Small InterferingTranscription FactorsZNF148 protein, human

Identifiers

PMID20850481
PMCPMC4051301
OpenAlexW2141330732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.